184 related articles for article (PubMed ID: 31750595)
41. Second head and neck cancers and tobacco usage.
Tomek MS; McGuirt WF
Am J Otolaryngol; 2003; 24(1):24-7. PubMed ID: 12579479
[TBL] [Abstract][Full Text] [Related]
42. Screening for head and neck second primary tumors in patients with esophageal squamous cell cancer: A systematic review and meta-analysis.
van de Ven S; Bugter O; Hardillo JA; Bruno MJ; Baatenburg de Jong RJ; Koch AD
United European Gastroenterol J; 2019 Dec; 7(10):1304-1311. PubMed ID: 31839955
[TBL] [Abstract][Full Text] [Related]
43. Primary lung cancer after treatment of head and neck cancer without lymph node metastasis: is there a role for autofluorescence bronchoscopy?
Lee P; de Bree R; Brokx HA; Leemans CR; Postmus PE; Sutedja TG
Lung Cancer; 2008 Dec; 62(3):309-15. PubMed ID: 18486989
[TBL] [Abstract][Full Text] [Related]
44. Synchronous second primary tumors in 2,016 head and neck cancer patients: role of symptom-directed panendoscopy.
Rennemo E; Zätterström U; Boysen M
Laryngoscope; 2011 Feb; 121(2):304-9. PubMed ID: 21271578
[TBL] [Abstract][Full Text] [Related]
45. Clinical features and treatment outcomes of Japanese head and neck cancer patients with a second primary cancer.
Yamashita T; Araki K; Tomifuji M; Tanaka Y; Harada E; Suzuki T; Miyamoto S; Shiotani A
Asia Pac J Clin Oncol; 2017 Jun; 13(3):172-178. PubMed ID: 27783469
[TBL] [Abstract][Full Text] [Related]
46. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms.
Aydiner A; Karadeniz A; Uygun K; Tas S; Tas F; Disci R; Topuz E
Am J Clin Oncol; 2000 Aug; 23(4):364-70. PubMed ID: 10955865
[TBL] [Abstract][Full Text] [Related]
47. Second primary tumors in patients with head and neck cancer.
Priante AV; Castilho EC; Kowalski LP
Curr Oncol Rep; 2011 Apr; 13(2):132-7. PubMed ID: 21234721
[TBL] [Abstract][Full Text] [Related]
48. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.
Argiris A; Brockstein BE; Haraf DJ; Stenson KM; Mittal BB; Kies MS; Rosen FR; Jovanovic B; Vokes EE
Clin Cancer Res; 2004 Mar; 10(6):1956-62. PubMed ID: 15041712
[TBL] [Abstract][Full Text] [Related]
49. Multiple primary cancer in patients with cancer of the head and neck: second cancer of the head and neck, esophagus, and lung.
Licciardello JT; Spitz MR; Hong WK
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):467-76. PubMed ID: 2674075
[TBL] [Abstract][Full Text] [Related]
50. Synchronous primary cancers of the head and neck region and upper aero digestive tract: defining high-risk patients.
Krishnatreya M; Rahman T; Kataki AC; Das A; Das AK; Lahkar K
Indian J Cancer; 2013; 50(4):322-6. PubMed ID: 24369209
[TBL] [Abstract][Full Text] [Related]
51. Metachronous mediastinal and lung metastases from head and neck cancer: A case series, literature review and considerations for treatment.
Ampil F; Previgliano C; Porter C; Richards T; Takalkar A
Oral Oncol; 2020 Mar; 102():104518. PubMed ID: 31862239
[TBL] [Abstract][Full Text] [Related]
52. Multiple primary tumours in patients with oral squamous cell carcinoma.
Cianfriglia F; Di Gregorio DA; Manieri A
Oral Oncol; 1999 Mar; 35(2):157-63. PubMed ID: 10435150
[TBL] [Abstract][Full Text] [Related]
53. Current concepts in the management of a second malignancy of the lung in patients with head and neck cancer.
Douglas WG; Rigual NR; Loree TR; Wiseman SM; Al-Rawi S; Hicks WL
Curr Opin Otolaryngol Head Neck Surg; 2003 Apr; 11(2):85-8. PubMed ID: 14515084
[TBL] [Abstract][Full Text] [Related]
54. Multiple primary tumours following head and neck cancer in southern England during 1961-98.
Warnakulasuriya KA; Robinson D; Evans H
J Oral Pathol Med; 2003 Sep; 32(8):443-9. PubMed ID: 12901724
[TBL] [Abstract][Full Text] [Related]
55. A nationwide population-based study to access the risk of metachronous esophageal cancers in head and neck cancer survivors.
Tseng CM; Wang HH; Lee CT; Tai CM; Tseng CH; Chen CC; Tsai YN; Chen TH; Hsu MH; Wang CC; Hwang TZ; Wang HP; Wang WL
Sci Rep; 2020 Jan; 10(1):884. PubMed ID: 31964952
[TBL] [Abstract][Full Text] [Related]
56. Incidence of squamous cell carcinomas of the head and neck following prolonged pegylated liposomal doxorubicin.
Rose PG; Fu F; Chambers LM; Mei L; De Bernardo R; Prendes BL; Lamarre E
Anticancer Drugs; 2020 Aug; 31(7):747-750. PubMed ID: 32697468
[TBL] [Abstract][Full Text] [Related]
57. Synchronous and Metachronous Malignancies After Malignant Struma Ovarii in the SEER Database.
Sisti A; Tassinari J; Nisi G; Grimaldi L; Sisti G; DI Tommaso M; Fambrini M
In Vivo; 2016 09-10; 30(5):713-6. PubMed ID: 27566096
[TBL] [Abstract][Full Text] [Related]
58. Multiple malignant primary tumors (non-head and neck): Contemplation needed.
Naorem R; Ghogale KS; Waghmare CM
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S752-S757. PubMed ID: 38384051
[TBL] [Abstract][Full Text] [Related]
59. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
Jain KS; Sikora AG; Baxi SS; Morris LG
Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
[TBL] [Abstract][Full Text] [Related]
60. Second primary lung cancers following a diagnosis of primary head and neck cancer.
Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
